4//SEC Filing
Bakshi Akash 4
Accession 0001104659-21-000919
CIK 0001638287other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:09 PM ET
Size
6.8 KB
Accession
0001104659-21-000919
Insider Transaction Report
Form 4
Bakshi Akash
DirectorSVP and COO
Transactions
- Award
Common Stock
2020-12-31+855,059→ 884,072 total(indirect: See Footnote) - Award
Common Stock
2020-12-31+29,013→ 29,013 total
Footnotes (2)
- [F1]Received in exchange for shares of ANA Therapeutics, Inc. ("ANA") common stock in connection with the acquisition of ANA by the Company.
- [F2]The reportable securities are owned directly by YourChoice Holdings, LLC ("YourChoice"). Mr. Bakshi is the CEO and a director of YourChoice. Mr. Bakshi disclaims beneficial ownership of the securities reported herein for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
NeuroBo Pharmaceuticals, Inc.
CIK 0001638287
Entity typeother
Related Parties
1- filerCIK 0001836243
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:09 PM ET
- Size
- 6.8 KB